Head-to-head · WeighScore
Elara Health and Wellness vs MyDrHank
By GLP-1 ScorecardUpdated
Score comparison
Elara Health and Wellness has the higher recorded score — 82.1/100 to 68.2/100.
Elara Health and Wellness grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Four-week self-pay bundles with labs and coaching; lower prepaid rates require upfront payment.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Elara Health and Wellness | MyDrHank |
|---|---|---|
| WeighScore | 82.1/100 | 68.2/100 |
| Grade | B− | C |
| Site position | #29 | #105 |
| Semaglutide | $249 every 4 weeks (injection; no prepayment); oral $279 every 4 weeks | From $171/mo oral or injectable on GLP-1 lander; injection product page from $178/mo (conflicting offer terms; confirm) |
| Tirzepatide | $339 every 4 weeks (no prepayment) | From $200/mo on GLP-1 lander; product page from $240/mo (conflicting offer terms; confirm) |
| Coverage | Advertises all 50 states + DC; confirm state eligibility | Confirm prescription and state; contiguous-U.S. shipping claim does not establish individual eligibility |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Strengths
- Four-week option without prepayment
- Quarterly labs and coaching advertised included
- Injection and oral semaglutide options
What to consider
- Prepaid refunds require shorter-plan reconciliation
- Confirm state, pharmacy and selected invoice
- Compounded formulations; independent credentials unverified
Site position #105 · C
Strengths
- Public landing and product pages show starting prices before medical intake
- Compounded injection options and a separate oral semaglutide menu are advertised, with formulation differences to discuss with the prescriber
- Product pages advertise consultation, delivery, check-ins and unlimited clinical messaging; response times were not tested
- Terms identify the platform operator and offer the current pharmacy-partner list on request
What to consider
- The GLP-1 lander shows $171/$200 injectable starting rates, while separate injection pages show $178/$240; applicable purchase terms remain unresolved
- Published base plan fields do not establish that a particular promotion is unavailable or what an individual will actually pay
- The reviewed GLP-1 terms did not establish the cancellation cutoff, unused-prepayment refund formula or declined-treatment financial outcome
- The assigned medical practice, prescriber and dispensing location remain unestablished; no current individual license verification is claimed
- Dose, concentration, usable supply, laboratory costs and state-specific availability require confirmation
- Compounded preparations are not FDA-approved; displayed branded-product trial results do not establish outcomes for these formulations
Featured provider
MyDrHank
MyDrHank scores 68.2/100 (C). MyDrHank advertises compounded tablets and injections, but its GLP-1 landing page and separate product pages show different starting prices; get one written offer before choosing a term.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.